CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Operating Income Growth by Quarter and Year

Merck And Co Inc 's Operating Income results by quarter and year




MRK Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 2,567.00 2,714.00 1,861.00
III Quarter September - 2,382.00 2,493.00 114.00
II Quarter June - 3,399.00 2,038.00 2,497.00
I Quarter March 3,909.00 3,255.00 1,054.00 2,061.00
FY   3,909.00 11,603.00 8,299.00 6,533.00



MRK Operating Income first quarter 2020 Y/Y Growth Comment
Merck and Co Inc achieved in the first quarter, above Company average Operating Income growth of 20.09% year on year, to $ 3,909.00 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 13 other companies have achieved higher Operating Income growth. While Merck And Co Inc ' s Operating Income rise of 20.09% ranks overall at the positon no. 343 in the first quarter.

Explain Operating Income growth


MRK Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - -5.42 % 45.84 % -
III Quarter September - -4.45 % 2086.84 % -96.08 %
II Quarter June - 66.78 % -18.38 % 63.95 %
I Quarter March 20.09 % 208.82 % -48.86 % 23.27 %
FY   - 39.81 % 27.03 % 21.45 %

Financial Statements
Merck And Co Inc 's first quarter 2020 Operating Income $ 3,909.00 millions MRK's Income Statement
Merck And Co Inc 's first quarter 2019 Operating Income $ 3,255.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Operating Income Growth >>


MRK Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - 7.77 % 8.86 % 1532.46 %
III Quarter September - -29.92 % 22.33 % -95.43 %
II Quarter June - 4.42 % 93.36 % 21.15 %
I Quarter March 52.28 % 19.93 % -43.36 % -
FY (Year on Year)   - 39.81 % 27.03 % 21.45 %




Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #42
Overall #343

Operating Income Y/Y Growth Statistics
High Average Low
1067.22 % 19.36 % -89.25 %
(Dec. 30, 2008)   (Dec. 30, 2007)
Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #42
Overall #343
Operating Income Y/Y Growth Statistics
High Average Low
1067.22 % 19.36 % -89.25 %
(Dec. 30, 2008)   (Dec. 30, 2007)

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Merck And Co Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
1532.46 % 38.63 % -95.43 %
(Dec 31 2017)  


MRK's I. Quarter Q/Q Operating Income Comment
Merck and Co Inc achieved in the I. Quarter 2020 above company average sequential Operating Income jump of 52.28%, to $ 3,909.00 millions, from $2,567.00 millions in the forth quarter.
MRK is going from strength to strength, not just claiming higher then regular increase, and also increasing speed, Tommaso Romano, Healthcare sector consultant based in Milan mentioned.

Within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Operating Income quarter on quarter growth. While Merck And Co Inc 's Operating Income growth quarter on quarter, overall rank is 204.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #18
Overall #204
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #18
Overall #204
Operating Income Q/Q Growth Statistics
High Average Low
1532.46 % 38.63 % -95.43 %
(Dec 31 2017)  


MRK's I. Quarter Q/Q Operating Income Comment
Merck and Co Inc achieved in the I. Quarter 2020 above company average sequential Operating Income jump of 52.28%, to $ 3,909.00 millions, from $2,567.00 millions in the forth quarter.
Major Pharmaceutical Preparations company is impressively improving, with reporting better then average increase, but also improving rate, Tommaso Romano, Healthcare sector consultant based in Milan said.

Within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Operating Income quarter on quarter growth. While Merck And Co Inc 's Operating Income growth quarter on quarter, overall rank is 204.


Merck And Co Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Operating Income 12 Months Ending $ 12,257.00 $ 11,603.00 $ 11,750.00 $ 11,861.00 $ 10,500.00
Y / Y Operating Income Growth (TTM) 16.73 % 39.81 % 57.8 % 134.08 % 90.01 %
Year on Year Operating Income Growth Overall Ranking # 376 # 203 # 212 # 174 # 237
Seqeuential Operating Income Change (TTM) 5.64 % -1.25 % -0.94 % 12.96 % 26.52 %
Seq. Operating Income Growth (TTM) Overall Ranking # 343 # 1495 # 982 # 449 # 193




Cumulative Operating Income growth Comment
With the quarterly Operating Income reported in the Mar 31 2020 period, Merck And Co Inc 's cumulative twelve months Operating Income were $ 12,257 millions, company would post below average annual Operating Income growth of 26.52% year on year, if the fiscal year would end at Mar 31 2020.
A slow-down in the Merck And Co Inc 's Operating Income growth from the 2567% growth in Dec 31 2019.

In the Healthcare sector 44 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 203 to 376.

Operating Income TTM Q/Q Growth Statistics
High Average Low
1067.22 %
19.36 %
-89.25 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 45
Overall # 376

Operating Income TTM Y/Y Growth Statistics
High Average Low
1129.36 %
67.67 %
-89.44 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 42
S&P 500 # 343
Cumulative Operating Income growth Comment
With the quarterly Operating Income reported in the Mar 31 2020 period, Merck And Co Inc 's cumulative twelve months Operating Income were $ 12,257 millions, company would post below average annual Operating Income growth of -89.44% year on year, if the fiscal year would end at Mar 31 2020.
A slow-down in the Merck And Co Inc 's Operating Income growth from the 2567% growth in Dec 31 2019.

In the Healthcare sector 44 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 203 to 376.

Operating Income TTM Q/Q Growth Statistics
High Average Low
1067.22 %
19.36 %
-89.25 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 45
Overall # 376

Operating Income TTM Y/Y Growth Statistics
High Average Low
1129.36 %
67.67 %
-89.44 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 42
S&P 500 # 343




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
MRK's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for MRK's Competitors
Operating Income Growth for Merck And Co Inc 's Suppliers
Operating Income Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Operating Income jump for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2020
Charles River Laboratories International inc   35.09 %$ 35.089 millions
Alexion Pharmaceuticals Inc   34.58 %$ 34.578 millions
Johnson and Johnson  31.46 %$ 31.456 millions
Bio rad Laboratories Inc   31.39 %$ 31.387 millions
Edwards Lifesciences Corporation  30.60 %$ 30.598 millions
Anika Therapeutics Inc   29.41 %$ 29.405 millions
Zoetis Inc   25.30 %$ 25.296 millions
West Pharmaceutical Services Inc   24.47 %$ 24.470 millions
China Health Industries Holdings Inc   23.94 %$ 23.944 millions
Standard Diversified Inc   23.64 %$ 23.641 millions
Biogen Inc   21.11 %$ 21.109 millions
Stryker Corp  20.27 %$ 20.265 millions
Merck and Co Inc   20.09 %$ 20.092 millions
Meridian Bioscience Inc  19.89 %$ 19.888 millions
Abbvie Inc   19.70 %$ 19.701 millions
Select Medical Holdings Corp  15.17 %$ 15.175 millions
Supernus Pharmaceuticals inc   14.09 %$ 14.095 millions
Millendo Therapeutics Inc   13.87 %$ 13.869 millions
Conmed Corporation  13.19 %$ 13.191 millions
Lhc Group Inc  12.48 %$ 12.478 millions
Intuitive Surgical Inc   12.21 %$ 12.213 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AITB's Profile

Stock Price

AITB's Financials

Business Description

Fundamentals

Charts & Quotes

AITB's News

Suppliers

AITB's Competitors

Customers & Markets

Economic Indicators

AITB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071